Dynamic Stress Perfusion CT for Detection of Inducible Myocardial Ischemia
SPECIFIC
Dynamic Stress Perfusion ct for Detection of Inducible Myocardial Ischemia
1 other identifier
observational
180
1 country
1
Brief Summary
The purpose of this study is to determine the diagnostic accuracy of MPICT for the detection of hemodynamically relevant coronary stenosis (as determined by invasive FFR) in patients with suspected or known CAD clinically referred for invasive angiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2016
CompletedStudy Start
First participant enrolled
June 7, 2016
CompletedFirst Posted
Study publicly available on registry
June 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2020
CompletedDecember 11, 2020
December 1, 2020
4.5 years
June 7, 2016
December 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Myocardial perfusion
invasive fractional flow reserve measurement
For each patient within 4 weeks of the CT perfusion acquisition
Secondary Outcomes (8)
Presence of myocardial perfusion defect on MPIMRI
For each patient within 1 week before invasive fractional flow reserve measurement
Per patient assessment of hemodynamically significant CAD
For each patient within 4 weeks of the CT perfusion acquisition
Ischemia per standardized myocardial segment
For each patient within 4 weeks of the CT perfusion acquisition
Coronary stenosis by CTA per territory (branch)
For each patient within 4 weeks of the CT perfusion acquisition
Coronary stenosis by invasive angiography per territory (branch)
For each patient within 4 weeks of the CT perfusion acquisition
- +3 more secondary outcomes
Interventions
Myocardial perfusion defect on dynamic CT perfusion imaging, and diagnostic accuracy as compared invasive FFR.
Eligibility Criteria
Patients with know or suspect coronary artery diseased, referred for invasive coronary angiography.
You may qualify if:
- Age 21-75 years
- Stable angina symptoms, suspected or known CAD, and referred for invasive angiography on clinical grounds.
- Ability to provide informed consent
- Ability to perform a 20-30 second breath hold
You may not qualify if:
- Hemodynamically and clinically unstable condition (angina at rest, malignant arrhythmias)
- Prior, documented myocardial infarction, other than (procedure related) minor type II myocardial infarction, which includes Q waves on the ECG or evidence of myocardial infarction on prior non-invasive imaging.
- Prior stenting or coronary artery bypass graft surgery
- Significant other cardiovascular conditions affecting the interpretation of MPICT, including, but not limited to: clinical heart failure, IECD (pacemaker/ICD), severe valvular heart disease or prosthetic valves, significant intra-cardiac shunting or other relevant congenital heart disease.
- eGFR\<60 ml/kg/min
- BMI\>30 kg/m2, or weight \>120 kg.
- Atrial fibrillation or other arrhythmia, \>6 ectopic beats / min
- Known or suspected allergy to iodinated contrast medium
- Pregnancy cannot be excluded
- Contra-indications for adenosine: bronchial asthma, second or third degree atrioventricular block, blood pressure \<110/70 mmHg, allergies or severe side effects in the past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- University Hospital Tuebingencollaborator
- Siemens Medical Solutionscollaborator
- Bayercollaborator
- University of Erlangen-Nürnbergcollaborator
- University Medical Center Groningencollaborator
- Mie Universitycollaborator
- University Hospital, Zürichcollaborator
- Queen Mary University of Londoncollaborator
- University Hospital Munichcollaborator
Study Sites (1)
ErasmusMC
Rotterdam, South Holland, 3015CE, Netherlands
Related Publications (2)
Soschynski M, Storelli R, Birkemeyer C, Hagar MT, Faby S, Schwemmer C, Nous FMA, Pugliese F, Vliegenthart R, Schlett CL, Nikolaou K, Krumm P, Nieman K, Bamberg F, Artzner CP. CT Myocardial Perfusion and CT-FFR versus Invasive FFR for Hemodynamic Relevance of Coronary Artery Disease. Radiology. 2024 Aug;312(2):e233234. doi: 10.1148/radiol.233234.
PMID: 39162632DERIVEDNous FMA, Geisler T, Kruk MBP, Alkadhi H, Kitagawa K, Vliegenthart R, Hell MM, Hausleiter J, Nguyen PK, Budde RPJ, Nikolaou K, Kepka C, Manka R, Sakuma H, Malik SB, Coenen A, Zijlstra F, Klotz E, van der Harst P, Artzner C, Dedic A, Pugliese F, Bamberg F, Nieman K. Dynamic Myocardial Perfusion CT for the Detection of Hemodynamically Significant Coronary Artery Disease. JACC Cardiovasc Imaging. 2022 Jan;15(1):75-87. doi: 10.1016/j.jcmg.2021.07.021. Epub 2021 Sep 15.
PMID: 34538630DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Koen Nieman, MD PHD
Erasmus Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. K. Nieman MD, PHD
Study Record Dates
First Submitted
June 7, 2016
First Posted
June 23, 2016
Study Start
June 7, 2016
Primary Completion
December 10, 2020
Study Completion
December 10, 2020
Last Updated
December 11, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share